Published in J Gastroenterol Hepatol on January 01, 1996
Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation. J Transplant (2012) 1.09
Liver transplantation in the UK. World J Gastroenterol (2001) 1.02
Delayed rearterialization unlikely leads to nonanastomotic stricture but causes temporary injury on bile duct after liver transplantation. Transpl Int (2014) 0.77
Chemokine Receptor-5Delta32 Mutation is No Risk Factor for Ischemic-Type Biliary Lesion in Liver Transplantation. J Transplant (2009) 0.77
New diagnosis and therapy model for ischemic-type biliary lesions following liver transplantation--a retrospective cohort study. PLoS One (2014) 0.77
Interventional radiology: management of biliary complications of liver transplantation. Semin Intervent Radiol (2004) 0.75
Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci U S A (2001) 6.78
Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J (1979) 5.58
Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut (1998) 3.77
Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut (1999) 3.36
Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. Clin Exp Immunol (1983) 3.21
Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques. Gut (1984) 2.74
T lymphocyte subsets in human intestinal mucosa: the distribution and relationship to MHC-derived antigens. Clin Exp Immunol (1981) 2.68
Community treatment of end-stage renal failure by dialysis and renal transplantation from cadaver donors. Lancet (1969) 2.53
Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis. J Clin Pathol (1983) 2.49
Immunohistological characterisation of intraepithelial lymphocytes of the human gastrointestinal tract. Gut (1981) 2.38
Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection. J Gastroenterol Hepatol (2007) 2.35
Lymphocyte subpopulations in the human small intestine. The findings in normal mucosa and in the mucosa of patients with adult coeliac disease. Clin Exp Immunol (1983) 2.34
Human T lymphocytes of inducer and suppressor type occupy different microenvironments. Nature (1980) 2.23
Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol (1999) 2.12
Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology (1996) 2.01
Terlipressin therapy for moderate-to-severe hyponatraemia in patients with liver failure. Intern Med J (2013) 2.00
Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus. BMJ (1997) 1.92
Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. Immunol Cell Biol (2001) 1.85
Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology (1999) 1.84
Controlled clinical trial of antilymphocyte globulin in patients with renal allografts from cadaver donors. Lancet (1971) 1.82
High-dose/activation-associated tolerance: a mechanism for allograft tolerance. Transplantation (1997) 1.65
A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation (2001) 1.61
Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut (1986) 1.58
T lymphocyte subsets in inflammatory bowel disease: peripheral blood. Gut (1983) 1.57
Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells. Gastroenterology (2000) 1.55
Olsalazine in active ulcerative colitis. Br Med J (Clin Res Ed) (1985) 1.55
Malignancy in a 19-year experience of adult celiac disease. Dig Dis Sci (1979) 1.54
CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scand J Immunol (2001) 1.53
The effect of heterologous immune serum on canine renal homografts. Transplantation (1966) 1.52
Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion. Semin Surg Oncol (1998) 1.51
Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. Mutat Res (2001) 1.51
Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut (1986) 1.49
Antigen-specific primary activation of CD8+ T cells within the liver. J Immunol (2001) 1.47
Pyogenic liver abscess: a review of 10 years' experience in management. Aust N Z J Surg (1999) 1.46
Physiological changes during liver transplantation. Anaesth Intensive Care (1989) 1.43
Saphenous-vein arteriovenous fistula in regular dialysis treatment. N Engl J Med (1969) 1.42
Multiple endoscopies in a Sydney blood donor found positive for hepatitis B and C antibodies. Med J Aust (1996) 1.40
Assessment and relevance of enzyme-linked immunosorbent assay for antibodies to Saccharomyces cerevisiae in Australian patients with inflammatory bowel disease. Intern Med J (2002) 1.40
Retrieval of organs for transplantation: experience of the Australian National Liver Transplantation Unit. Med J Aust (1996) 1.39
Effect of liver transplantation on islet allografts: up-regulation of Fas ligand and apoptosis of T lymphocytes are associated with islet graft tolerance. Transplantation (2001) 1.38
Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8. Eur J Biochem (2000) 1.32
Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res (1987) 1.27
Ulcerative colitis and persistent liver dysfunction. Q J Med (1983) 1.27
Characterization of the human homolog of the rat MRC OX-2 membrane glycoprotein. Immunogenetics (1987) 1.24
Long-term survival with tumor regression in androgen-induced liver tumors. Cancer (1985) 1.23
Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology (1996) 1.19
The gene for MRC OX-2 membrane glycoprotein is localized on human chromosome 3. Immunogenetics (1987) 1.18
False detection of negative-strand hepatitis C virus RNA. Lancet (1994) 1.18
Cancer and survival after cadaveric donor renal transplantation. Transplant Proc (1979) 1.18
Type III and type IV endoleak: toward a complete definition of blood flow in the sac after endoluminal AAA repair. J Endovasc Surg (1998) 1.16
Cancer development in patients progressing to dialysis and renal transplantation. Transplant Proc (1985) 1.14
Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepat (1997) 1.14
Inflammatory pseudotumor of the liver causing biliary obstruction. Treatment by biliary stenting with 5-year follow-up. J Clin Gastroenterol (1991) 1.09
Cancer in renal allograft recipients in Australia and New Zealand. Transplant Proc (1977) 1.09
Two highly conserved glutamic acid residues in the predicted beta propeller domain of dipeptidyl peptidase IV are required for its enzyme activity. FEBS Lett (1999) 1.09
Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection. Transplantation (1993) 1.08
Immunologic relationships between skin and kidney homografts in dogs on immunosuppressive therapy. Transplantation (1966) 1.07
Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Immunogenetics (1994) 1.06
Type I and Type II endoleaks: a more useful classification for reporting results of endoluminal AAA repair. J Endovasc Surg (1998) 1.06
Cancer following successful cadaveric donor renal transplantation. Transplant Proc (1981) 1.05
Antilymphocyte globulin in patients with renal allografts from cadaveric donors. Late results of a controlled trail. Lancet (1973) 1.04
Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B. Liver Transpl (2000) 1.04
Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution. Liver Transpl (2003) 1.03
Reversal of renal failure by revascularisation of kidneys with thrombosed renal arteries. Lancet (1973) 1.03
Iatrogenic incarceration of umbilical hernia in cirrhotic patients with ascites. Am J Gastroenterol (1995) 1.02
Neuronal/lymphoid membrane glycoprotein MRC OX-2 is a member of the immunoglobulin superfamily with a light-chain-like structure. Biochem Soc Symp (1986) 1.02
Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis. Gastroenterology (1994) 1.02
Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclear cell markers. Kidney Int (1986) 1.01
Deaths from occlusive arterial disease in renal allograft recipients. Br Med J (1974) 1.01
Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation (1995) 1.00
A controlled clinical trial of machine perfusion of cadaveric donor renal allografts. Lancet (1975) 0.98
Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis. Hepatology (1997) 0.98
Aortic occlusion and vascular isolation allowing avascular hepatic resection. Arch Surg (1990) 0.98
Topical treatment of distal ulcerative colitis with 4-amino-salicylic acid enemas. Digestion (1984) 0.97
Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance. Transplantation (1999) 0.97
Surgical management of complications following endoluminal grafting of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg (1995) 0.97
Bone loss after liver transplantation. Hepatology (1991) 0.97
Antibiotic-associated colitis and cystic fibrosis. Dig Dis Sci (1992) 0.96
The heterogeneity of bone disease in cirrhosis: a multivariate analysis. Osteoporos Int (2003) 0.96
Renal autotransplantation for severe loin-pain/haematuria syndrome. Lancet (1985) 0.95
Scheduled and unscheduled DNA synthesis in epidermal cells of hairless mice treated with immunosuppressive drugs and UVB-UVA irradiation. Br J Dermatol (1987) 0.95
Early up-regulation of macrophages and myofibroblasts: a new marker for development of chronic renal allograft rejection. Transplantation (2000) 0.95
Twenty and 25 years survival after cadaveric renal transplantation. Transplant Proc (1995) 0.94
Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantation. Hepatology (1996) 0.93
Natural killer cells and spontaneous cell-mediated cytotoxicity in the human intestine. Clin Exp Immunol (1984) 0.93
Spontaneous clearance of hepatitis C virus infection post-liver transplantation is associated with rapidly changing quasispecies: a single case report. Liver Transpl (2000) 0.93
Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients. Am J Transplant (2012) 0.93
Thrombocytopenia post liver transplantation. Correlations with pre-operative platelet count, blood transfusion requirements, allograft function and outcome. J Hepatol (1992) 0.93
Specific in vitro antibody responses by human blood lymphocytes: apparent nonresponsiveness of PBL is due to a lack of recirculating memory B cells. J Immunol (1982) 0.92
Ureteric injury at Burch colposuspension. 4 case reports and literature review. Aust N Z J Obstet Gynaecol (1996) 0.92
Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer. Cancer Epidemiol Biomarkers Prev (1997) 0.92